PHR:NYE-Phreesia Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 22.19

Change

+0.12 (+0.54)%

Market Cap

N/A

Volume

0.20M

Analyst Target

USD 30.11
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

+0.48 (+0.71%)

USD 10.78B
DOCS Doximity Inc

+0.46 (+1.06%)

USD 7.70B
WEAV Weave Communications Inc

+0.47 (+3.75%)

USD 0.89B
AMWL American Well Corp

+0.29 (+3.20%)

USD 0.14B
MPLN MultiPlan Corporation

+1.02 (+12.78%)

USD 0.12B
OWLT Owlet Inc

-0.07 (-1.53%)

USD 0.07B
STRM Streamline Health Solutions In..

+2.37 (+1,185.64%)

USD 0.01B
LFMDP LifeMD Inc Preferred Series A

-0.25 (-1.12%)

N/A
TDOC Teladoc Inc

+0.36 (+4.15%)

N/A
FOXO FOXO Technologies Inc.

N/A

N/A

ETFs Containing PHR

WELL:PA HAN-GINS Indxx Healthcare.. 1.18 % 0.00 %

+0.07 (+1.14%)

N/A
WELL:SW HAN-GINS Indxx Healthcare.. 1.18 % 0.00 %

+0.07 (+1.14%)

N/A
W311:XETRA HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

-0.01 (1.14%)

USD 0.02B
W311:F HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

+0.02 (+1.14%)

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.15% 67% D+ 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.15% 67% D+ 17% F
Trailing 12 Months  
Capital Gain 21.52% 83% B 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.52% 75% C 48% F
Trailing 5 Years  
Capital Gain -10.23% 60% D- 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.23% 60% D- 19% F
Average Annual (5 Year Horizon)  
Capital Gain 13.28% N/A N/A 75% C
Dividend Return 13.28% N/A N/A 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 68.16% N/A N/A 12% F
Risk Adjusted Return 19.48% N/A N/A 38% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector